Gender, racial and age differences in bladder cancer incidence and mortality

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 2, 2004, Pages 86-92

  Madeb, Ralph ^a   Messing, Edward M ^a  

^a STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

Bladder cancer; Epidemiology; Gender; Race; Risk factors

Indexed keywords

BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; EUROPE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; UNITED STATES;

AGE DISTRIBUTION; HUMANS; INCIDENCE; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 1842786020     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(03)00139-X     Document Type: Review

References (61)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin. 52:(1):2002;23-47.
2. Aben K.K., Kiemeney L.A. Epidemiology of bladder cancer. Eur Urol. 36:(6):1999;660-672.
3. Brauers A., Jakse G. Epidemiology and biology of human urinary bladder cancer. J Cancer Res Clin Oncol. 126:(10):2000;575-583.
4. Cohen S.M., Shirai T., Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol. 205:(Suppl):2000;105-115.
5. Goldstein M.M., Messing E.M. Prostate and bladder cancer screening. J Am Coll Surg. 86:(1):1998;63-74.
6. Lee R., Droller M.J. The natural history of bladder cancer Implications for therapy. Urol Clin North Am. 27:(1):2000;1-13.
7. Cheng L., Weaver A.L., Leibovich B.C., et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer. 88:(10):2000;2326-2332.
8. Thrasher J.B., Frazier H.A., Robertson J.E., Dodge R.K., Paulson D.F. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 73:(6):1994;1708-1715.
9. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J Clin. 51:(1):2001;15-36.
10. Marshall V.F. Current clinical problems regarding bladder tumors. Cancer. 3:1956;543-550.
11. Kishi K., Hirota T., Matsumoto K., Kakizoe T., Murase T., Fujita J. Carcinoma of the bladder a clinical and pathological analysis of 87 autopsy cases. J Urol. 125:(1):1981;36-39.
12. Trussel J. Women's longevity. Science. 270:1995;720-721.
13. Micheli A., Mariotto A., Giorgi Rossi A., Gatta G., Muti P. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer. 34:(14):1998;2271-2278.
14. Reis L.A.G., Kosary C.L., Hankey B.F., et al. SEER Cancer Statistics Reviews, 1973-1996. 1997;National Cancer Institute, Bethesda.
15. Schairer C., Hartge P., Hoover R.N., Silverman D.T. Racial differences in bladder cancer risk a case-control study. Am J Epidemiol. 128:(5):1988;1027- 1037.
16. Prout G.R. Jr, Wesley M.N., Greenberg R.S., et al. Bladder cancer race differences in extent of disease at diagnosis. Cancer. 89:(6):2000;1349-1358.
17. Teppo L., Dickman P.W., Hakulinen T., et al. Cancer patient survival-patterns, comparisons, trends a population-based Cancer Registry study in Finland. Acta Oncol. 38:(3):1999;283-294.
18. Dickman P.W., Hakulinen T., Luostarinen T., et al. Survival of cancer patients in Finland 1955-1994. Acta Oncol. 38:(Suppl 12):1999;1-103.
19. Kiemeney L.A., Coebergh J.W., Koper N.P., et al. Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer. 30A:(8):1994;1134-1137.
20. Fleshner N.E., Herr H.W., Stewart A.K., Murphy G.P., Mettlin C., Menck H.R. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 78:(7):1996;1505-1513.
21. Mungan N.A., Kiemeney L.A., van Dijck J.A., van der Poel H.G., Witjes J.A. Gender differences in stage distribution of bladder cancer. Urology. 55:(3):2000;368-371.
22. Marshall V.F. Symposium on bladder tumors current clinical problems regarding bladder tumors. Cancer. 9:1956;543.
23. Messing E.M. Urothelial tumors of the urinary tract. Walsh P.C., Retik A., Vaughan E.D. Jr, Wein A. Campbell's urology. 2002;2732-2784 WB Saunders, Philadelphia.
24. Mommsen S., Aagaard J., Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol. 17:(2):1983;163-167.
25. Mansson A., Anderson H., Colleen S. Time lag to diagnosis of bladder cancer-influence of psychosocial parameters and level of health-care provision. Scand J Urol Nephrol. 27:(3):1993;363-369.
26. Wei J.T., Olapade-olaopa E.O., Montie J.E. Does delay in performing a radical cystectomy affect final pathologic stage? J Urol. 165:(Suppl 5):2001;1246. [abstr].
27. Sanchez-Ortiz R.F., Huang W.C., Mick R., Van Arsdalen K.N., Wein A.J., Malkowicz S.B. J Urol. 169:(1):2003;110-115.
28. Micheli A., Mariotto A., Rossi A.G., Gatta G., Muti P. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer. 34:(14):1998;2271-2278.
29. Mechanic D. the concept of illness behaviour. J Chron Dis. 15:1962;189-194.
30. Cleary P.D., Mechanic D., Greenley J.R. Sex differences in medical care utilization an empirical investigation. J Health Soc Behaviour. 23:1982;106-119.
31. Gove W.R., Hughes M. Possible causes of the apparent sex differences in physical health an empirical investigation. Am Soc Review. 44:1979;126-146.
32. Wallen J., Waitzkin H., Stoeckle J.D. Physician stereotypes about female and health and illness. Women and Health. 4:1979;135-146.
33. Hayes R.B., Friedell G.H., Zahm S.H., Cole P. Are the known bladder cancer risk-factors associated with more advanced bladder cancer? Cancer Causes Control. 4:(2):1993;157-162.
34. Maralani S., Wood D.P. Jr, Grignon D., Banerjee M., Sakr W., Pontes J.E. Incidence of urethral involvement in female bladder cancer an anatomic pathologic study. Urology. 50:(4):1997;537-541.
35. Mungan N.A., Aben K.K., Schoenberg M.P., et al. Gender differences in stage-adjusted bladder cancer survival. Urology. 55:(6):2000;876-880.
36. Bach P.B., Schrag D., Brawley O.W., Galaznik A., Yakren S., Begg C.B. Survival of blacks and whites after a cancer diagnosis. JAMA. 287:(16):2002;2106-2113.
37. Howard J., Hankey B.F., Greenberg R.S., et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 69:(9):1992;2349-2360.
38. Eley J.W., Hill H.A., Chen V.W., Austin D.F., et al. Racial differences in survival from breast cancer Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 272:(12):1994;947-954.
39. Steinhorn S.C., Myers M.H., Hankey B.F., Pelham V.F. Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am J Epidemiol. 124:(1):1986;85-93.
40. Evans L.A. Black and white differences narrowing the gap in cancer medicine. In Vivo. 6:(4):1992;429-434.
41. Elledge R.M., Clark G.M., Chamness G.C., Osborne C.K. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 86:(9):1994;705-712.
42. Shiao Y.H., Chen V.W., Wu X.C., et al. Racial comparison of p53 alterations in breast cancer difference in prognostic value. In Vivo. 10:(2):1996;169-173.
43. Shiao Y.H., Chen V.W., Scheer W.D., Wu X.C., Correa P. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res. 55:(7):1995;1485-1490.
44. Baquet C.R., Commiskey P. Socioeconomic factors and breast carcinoma in multicultural women. Cancer. 88:(Suppl 5):2000;1256-1264.
45. Lannin D.R., Mathews H.F., Mitchell J., Swanson M.S., Swanson F.H., Edwards M.S. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 279:(22):1998;1801-1807.
46. Mandelblatt J., Andrews H., Kerner J., Zauber A., Burnett W. Determinants of late stage diagnosis of breast and cervical cancer the impact of age, race, social class, and hospital type. Am J Public Health. 81:(5):1991;646-649.
47. Jepson C., Kessler L.G., Portnoy B., Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 81:(4):1991;501-504.
48. Robinson R.G., Kessler L.G., Naughton M.D. Cancer awareness among African Americans a survey assessing race, social status, and occupation. J Natl Med Assoc. 83:(6):1991;491-497.
49. Potosky A.L., Harlan L.C., Kaplan R.S., Johnson K.A., Lynch C.F. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 20:(5):2002;1192-11202.
50. Canto M.T., Chu K.C. Annual cancer incidence rates for Hispanics in the United States surveillance, epidemiology, and end results, 1992-1996. Cancer. 88:(11):2000;2642-2652.
51. Droller M.J. Bladder cancer state of the art care. CA Cancer J Clin. 48:1998;269-284.
52. Silverman D.T., Morrison A.S., Devesa S.S. Bladder Cancer. Schottenfeld D. Cancer epidemiology and prevention. 1996;1156-1179 Oxford University Press, New York.
53. Pamuk E., Makuc D., Heck K., Reuben C., Lochner K. Socioeconomic status and health chartbook. Health, United States. U. S. department of Health and Human Services publication number (PHS): 98-1232. 1998;National Center for Health Statistics, Hyattsville, MD.
54. Benson R.C. Jr, Tomera K.M., Kelalis P.P. Transitional cell carcinoma of the bladder in children and adolescents. J Urol. 130:(1):1983;54-55.
55. Fitzpatrick J.M., Reda M. Bladder carcinoma in patients 40 years old or less. J Urol. 135:(1):1986;53-54.
56. Linn J.F., Sesterhann I., Mostofi F.K., Schoenberg M. The molecular characteristics of bladder cancer in young patients. J Urol. 159:1998;1493.
57. Wymenga A.N., Slaets J.P., Sleijfer D.T. Treatment of cancer in old age, shortcomings and challenges. Neth J Med. 59:(5):2001;259-266.
58. Miller D.C., Taub D.A., Dunn R.L., Montie J.E., Wei J.T. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol. 169:(1):2003;105-109.
59. Edwards B.K., Howe H.L., Ries L.A., et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 94:(10):2002;2766-2792.
60. Yancik R., Ries L.A. Aging and cancer in America Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am. 14:(1):2000;17-23.
61. Herr H.W. Does early cystectomy improve survival of patients with high-risk nonmuscle invasive bladder tumors. J Urol. 165:(Suppl 5):2001;1061. [abstr].